A rapid screening assay for identifying mycobacteria targeted nanoparticle antibiotics. Issue 6 (2nd July 2016)
- Record Type:
- Journal Article
- Title:
- A rapid screening assay for identifying mycobacteria targeted nanoparticle antibiotics. Issue 6 (2nd July 2016)
- Main Title:
- A rapid screening assay for identifying mycobacteria targeted nanoparticle antibiotics
- Authors:
- Donnellan, Samantha
Tran, Lang
Johnston, Helinor
McLuckie, Joyce
Stevenson, Karen
Stone, Vicki - Abstract:
- Abstract: Antibiotic resistance is a serious problem. Nanotechnology offers enormous potential in medicine, yet there is limited knowledge regarding the toxicity of nanoparticles (NP) for mycobacterial species that cause serious human diseases (e.g. tuberculosis (TB) and leprosy). Mycobacterial diseases are a major global health problem; TB caused by Mycobacterium tuberculosis ( Mtb ) kills up to 2 million people annually and there are over 200 000 leprosy cases each year caused by Mycobacterium leprae ( M. leprae ). Few drugs are effective against these mycobacteria and increasing antibiotic resistance exacerbates the problem. As such, alternative therapies are urgently needed but most current assays used to assess the effectiveness of therapeutics against mycobacteria are slow and expensive. This study aimed to develop a rapid, low-cost assay which can be used for screening the antimicrobial properties of compounds against pathogenic mycobacteria and to assess the toxicity of three NP (silver [Ag], copper oxide [Cu(II)O], and zinc oxide [ZnO]) against a green fluorescent protein reporter strain of Mycobacterium avium subspecies paratuberculosis, a slow growing, pathogenic mycobacterial species causing paratuberculosis in ruminants. Fluorescence was used to monitor mycobacterial growth over time, with NP concentrations of 6.25–100 μg/mL tested for up to 7 days, and a method of data analysis was designed to permit comparison between results. Mycobacterial sensitivity to theAbstract: Antibiotic resistance is a serious problem. Nanotechnology offers enormous potential in medicine, yet there is limited knowledge regarding the toxicity of nanoparticles (NP) for mycobacterial species that cause serious human diseases (e.g. tuberculosis (TB) and leprosy). Mycobacterial diseases are a major global health problem; TB caused by Mycobacterium tuberculosis ( Mtb ) kills up to 2 million people annually and there are over 200 000 leprosy cases each year caused by Mycobacterium leprae ( M. leprae ). Few drugs are effective against these mycobacteria and increasing antibiotic resistance exacerbates the problem. As such, alternative therapies are urgently needed but most current assays used to assess the effectiveness of therapeutics against mycobacteria are slow and expensive. This study aimed to develop a rapid, low-cost assay which can be used for screening the antimicrobial properties of compounds against pathogenic mycobacteria and to assess the toxicity of three NP (silver [Ag], copper oxide [Cu(II)O], and zinc oxide [ZnO]) against a green fluorescent protein reporter strain of Mycobacterium avium subspecies paratuberculosis, a slow growing, pathogenic mycobacterial species causing paratuberculosis in ruminants. Fluorescence was used to monitor mycobacterial growth over time, with NP concentrations of 6.25–100 μg/mL tested for up to 7 days, and a method of data analysis was designed to permit comparison between results. Mycobacterial sensitivity to the NP was found to be NP composition specific and toxicity could be ranked in the following order: Ag > Cu(II)O > ZnO. … (more)
- Is Part Of:
- Nanotoxicology. Volume 10:Issue 6(2016:Sep.)
- Journal:
- Nanotoxicology
- Issue:
- Volume 10:Issue 6(2016:Sep.)
- Issue Display:
- Volume 10, Issue 6 (2016)
- Year:
- 2016
- Volume:
- 10
- Issue:
- 6
- Issue Sort Value:
- 2016-0010-0006-0000
- Page Start:
- 761
- Page End:
- 769
- Publication Date:
- 2016-07-02
- Subjects:
- Antibacterial activity -- antibiotic resistance -- drug screening -- mycobacterium -- nanomedicine
Toxicology -- Periodicals
615.9 - Journal URLs:
- http://informahealthcare.com/loi/nan ↗
http://www.tandfonline.com/toc/inan20/current ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/17435390.2015.1124468 ↗
- Languages:
- English
- ISSNs:
- 1743-5390
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6015.335549
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2037.xml